A sustained-release enteric-coated preparation of duloxetine, core material and preparation method thereof

A technology for duloxetine and enteric-coated preparations, which is applied in the field of duloxetine slow-release enteric-coated preparations and its core materials and preparations, which can solve problems such as adverse reactions and solvent residues, reduce solvent residues, and improve stability The effect of simplification and simplification of operation steps

Active Publication Date: 2012-02-22
SHANGHAI ZHONGXI PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Therefore, the technical problem to be solved in the present invention is that the core material of the existing duloxetine enteric-coated preparation is in contact with water or organic solvents during the preparation process, which causes the partial degradation of the active ingredient duloxetine and the shortage of solvent residues. And after the existing duloxetine hydrochloride enteric-coated solid preparation is taken, some patients will have the defect of adverse reactions in terms of gastrointestinal disorders, and provide a new duloxetine core material, enteric-coated preparation and its preparation The method, the duloxetine core material does not contact any water and organic solvents during the preparation process, the active ingredient duloxetine has little degradation and high stability, and the duloxetine enteric-coated preparation passes through the artificial gastric juice, and at pH6 .8 In phosphate buffer solution, the release amount in 1 hour is less than 50% of the labeled amount, and the release amount in 4 hours is greater than 70% of the labeled amount

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A sustained-release enteric-coated preparation of duloxetine, core material and preparation method thereof
  • A sustained-release enteric-coated preparation of duloxetine, core material and preparation method thereof
  • A sustained-release enteric-coated preparation of duloxetine, core material and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1 Enteric-coated tablets

[0029] formula:

[0030]

[0031] Preparation Process:

[0032] Mix duloxetine hydrochloride, PEG8000, stearic acid and poloxamer, put it in a quick mixer with a jacket temperature of 82℃, turn on the mixer of the granulator, when the material temperature reaches 60℃, continue to stir to make 24 mesh Granules of different sizes are discharged, cooled, and granulated with a 24-mesh sieve. Add talcum powder and magnesium stearate, mix evenly, and press tablets to obtain tablet cores.

[0033] Isolation layer operation: In this example, duloxetine hydrochloride enteric-coated tablets were prepared. The coating preparation process is: disperse hypromellose with 70°C hot water, add water and stir to dissolve, add homogenized talc powder and Sucrose is made into a separation layer solution with a solid content of about 15% by weight. Put the tablet core in a coating pan to coat the isolation layer.

[0034] Enteric layer operation: add triethyl ci...

Embodiment 2

[0035] Example 2 Enteric-coated tablets

[0036] formula:

[0037]

[0038] Preparation Process:

[0039] Mix duloxetine hydrochloride, PEG6000, stearic acid, hydrogenated oil and poloxamer, put it in a quick mixer with a jacket temperature of 82℃, turn on the agitator of the granulator, when the material temperature reaches 60℃, continue to stir Into 24 mesh size particles, discharge, cool, and use a 24 mesh sieve to size. Add magnesium stearate, mix evenly, and press tablets to obtain tablet cores.

[0040] Isolation layer operation: In this example, duloxetine hydrochloride enteric-coated tablets were prepared. The coating preparation process is: disperse hypromellose with 70°C hot water, add water and stir to dissolve, add homogenized talc powder and Titanium dioxide is made into a separation layer solution with a solid content of about 15% by weight. Put the tablet core in a coating pan to coat the isolation layer.

[0041] Enteric layer coating: Acrylic MP is prepared as a 20w...

Embodiment 3

[0042] Example 3 Enteric-coated tablets

[0043] formula:

[0044]

[0045]

[0046] Preparation Process:

[0047] Mix duloxetine hydrochloride, PEG6000, hydrogenated castor oil and sucrose, put it in a quick mixer with a jacket temperature of 87℃, turn on the mixer of the granulator, when the material temperature reaches 65℃, continue to stir to make 24 mesh size The particles are discharged, cooled, and sized with a 24-mesh sieve. Add magnesium stearate, mix evenly, and press tablets to obtain tablet cores.

[0048] Isolation layer coating: Disperse hypromellose with 70℃ hot water and stir to dissolve it with water; take half of the solution, add homogenized talc, titanium dioxide and sucrose to make a solution with a solid content of about 15% by weight. The core is placed in a coating pan for coating; then magnesium oxide is added to the remaining half of the hypromellose solution to make a solution with a solid content of about 10 wt% for coating.

[0049] Enteric layer coating:...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a Duloxetine nteric-coated sustained release preparation as well as a core material and a preparation method thereof. The core material consists of Duloxetine as active medicinal ingredient or salts thereof and pharmaceutically acceptable auxiliary, wherein the pharmaceutically acceptable auxiliary contains a hot-melt material which at least contains a water-soluble hot-melt material and a hydrophobic hot-melt material, and the content of the hot-melt material is 20%-35%, the content of Duloxetine or salts thereof is 50%-75%, the rest is other pharmaceutically acceptable auxiliary the percentage of which is the mass percentage thereof based on the total amount of the core material. According to the invention, the core material of the Duloxetine nteric-coated sustained release preparation is prepared by adopting hot-melt technology, which avoids the introduction of water or organic solvents during preparation, lessens the degradation of principal and residual solvent, achieves a proper delay on the release of Duloxetine in intestines, namely 4-hour release amount in phosphate buffer with 6.8 of pH accounting for over 70% of the total amount, and is favorable for reducing adverse reaction of patients.

Description

Technical field [0001] The invention belongs to the field of pharmaceutical preparations, and particularly relates to a slow-release enteric preparation of duloxetine, a core material and a preparation method thereof. Background technique [0002] Duloxetine is a selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It is a safe and effective antidepressant with the chemical name (S)-(+)-N-methyl 3-(1-naphthyloxy)-3-(2-thienyl)-propylamine is usually used in the form of hydrochloride. The elimination half-life of duloxetine hydrochloride is about 12 hours (variation range is 8-17 hours). Within the treatment range, its pharmacokinetic parameters are proportional to the dose, and the steady-state plasma concentration is generally reached after 3 days of taking the drug. [0003] Because duloxetine is unstable and prone to degradation in an acidic environment, it is appropriate to make duloxetine or its salt into an enteric-coated preparation to resist gastric juice fr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/381A61K47/38A61K9/24A61K47/34A61P25/24A61K47/10A61K47/12A61K47/14A61K47/44
Inventor 郑斯骥丁云晖任亚洲
Owner SHANGHAI ZHONGXI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap